Understanding brain haemorrhage causes and classifications

Traumatic and Iatrogenic Triggers in Brain Hemorrhage

The biomechanical forces underlying traumatic hemorrhages vary by hemorrhage type, with acceleration/deceleration and blunt impact playing pivotal roles. Iatrogenic triggers, conversely, emerge from surgical manipulations, catheter-based interventions, or pharmacological agents that alter coagulation or vascular tone. Below, the biomechanical distinctions between epidural and subdural hematomas are examined, followed by an analysis of high-risk surgical procedures and non-surgical iatrogenic pathways. A comparative table further elucidates the role of recreational drugs in precipitating hemorrhage through direct or indirect vascular mechanisms.

Biomechanical Forces in Traumatic Brain Hemorrhage

Epidural Hematomas
Epidural hematomas result from high-velocity rotational or linear acceleration/deceleration forces, typically associated with temporal bone fractures or skull base trauma. The middle meningeal artery (MMA), a branch of the maxillary artery, is the most commonly injured vessel due to its adherence to the inner table of the skull. When the skull undergoes rapid deceleration, the MMA may tear at its dural insertion point, creating a lentiform (biconvex) hematoma that expands rapidly due to arterial pressure. Blunt trauma to the temporal region (e.g., falls, motor vehicle collisions) is the predominant mechanism, though penetrating injuries can also disrupt the MMA.

Key Biomechanical Feature of EDHs:
"Arterial bleeding under high pressure within a confined epidural space, leading to rapid mass effect and midline shift."

Key Biomechanical Feature of SDHs:
"Venous bleeding from bridging veins due to rotational shear, often associated with diffuse axonal injury or chronic subdural atrophy."

Surgical Procedures and Iatrogenic Hemorrhage

High-Risk Surgical Interventions

Surgical procedures involving direct dural or cortical penetration pose the greatest hemorrhage risk due to disruption of meningeal or parenchymal vessels. Key examples include:
1. Craniotomy and Craniectomy
   The middle meningeal artery and superficial cortical veins are frequently encountered during dural opening. Burr hole placement may inadvertently lacerate the MMA if the trajectory deviates from the planned trajectory, particularly in patients with pre-existing vascular anomalies (e.g., arteriovenous malformations). Delayed epidural hemorrhage can occur if small arterial branches are not adequately cauterized or sealed.
2. Stereotactic Biopsy
   Deep brain biopsies targeting lesions near the thalamus, basal ganglia, or brainstem risk penetrating perforating arteries (e.g., lenticulostriate arteries). Intraparenchymal hemorrhage may result from direct arterial puncture or post-procedural reperfusion injury in highly vascular tumors (e.g., gliomas).
3. Ventriculoperitoneal (VP) Shunt Placement
   Choroid plexus injury during ventricular catheter insertion can lead to subdural or intraventricular hemorrhage, particularly in pediatric patients with thin cortical veins. Delayed hemorrhage may occur if the shunt system malfunctions, causing increased intracranial pressure (ICP) and venous congestion.
4. Endovascular Procedures (e.g., Aneurysm Clipping, Coiling)
   Catheter-related arterial dissection or thromboembolic complications from stent placement can precipitate subarachnoid hemorrhage (SAH) or intracerebral hemorrhage (ICH). Delayed hemorrhage may arise from rebleeding of incompletely secured aneurysms or vasospasm-induced rupture.

Strategies to mitigate iatrogenic hemorrhage during neurosurgery include:
1. Intraoperative Hemostatic Agents
   Topical hemostatic agents such as gelatin matrix (e.g., Surgicel®), fibrin glue (e.g., Tisseel®), or chitosan-based sealants are applied to bleeding surfaces post-dural incision. Flowable hemostatic matrices (e.g., Floseal®) are particularly useful for diffuse oozing from cortical veins.
2. Real-Time Imaging Guidance
   Intraoperative MRI (iMRI) or ultrasound allows for dynamic visualization of vascular structures, reducing the risk of unexpected arterial injury during biopsy or shunt placement. Indocyanine green (ICG) angiography is used to identify vascular anomalies preemptively.
3. Coagulation Optimization
   Preoperative correction of coagulopathy (e.g., vitamin K for warfarin reversal, platelet transfusion for thrombocytopenia) is critical. Recombinant factor VIIa (rFVIIa) may be considered in refractory bleeding during craniotomy, though its use is controversial due to thromboembolic risks.
4. Minimally Invasive Techniques
   Endoscopic-assisted procedures (e.g., endoscopic third ventriculostomy) reduce direct trauma to bridging veins, lowering the risk of subdural hemorrhage. Robot-assisted stereotaxy improves precision in biopsy trajectories, minimizing parenchymal vessel injury.

Non-Surgical Iatrogenic Causes of Brain Hemorrhage

Lumbar Puncture Complications

Lumbar puncture (LP) is a low-risk procedure when performed correctly, but iatrogenic subdural or epidural hemorrhage can occur due to:
1. Trauma to Epidural or Subdural Veins
   Needle misplacement during LP can puncture epidural venous plexuses, leading to epidural hematoma—particularly in patients with coagulopathy or anticoagulant therapy. Delayed hemorrhage
   

   Genetic and Congenital Factors in Brain Hemorrhage

   Brain hemorrhage due to genetic and congenital factors arises from inherited or developmental defects in vascular structure, collagen synthesis, or endothelial integrity. These conditions often manifest as spontaneous hemorrhages, particularly in young adults or children, and may present with atypical clinical features such as cutaneous lesions, family history of strokes, or recurrent epistaxis. Understanding their molecular pathways, inheritance patterns, and age-specific presentations is critical for early diagnosis and targeted management.

   Genetic predispositions to hemorrhage typically involve mutations in genes regulating vascular formation, extracellular matrix stability, or signaling pathways. Congenital anomalies, while less common than acquired causes, account for a significant proportion of hemorrhagic strokes in pediatric and young adult populations. Below, the key genetic syndromes, connective tissue disorders, and rare vascular anomalies are examined, alongside their diagnostic markers and hemorrhage patterns.
   

   Hereditary Hemorrhagic Telangiectasia (HHT) and Cavernous Malformations

   Hereditary hemorrhagic telangiectasia (HHT), also known as Rendu-Osler-Weber syndrome, is an autosomal dominant disorder characterized by abnormal blood vessel formation (telangiectasias) and arteriovenous malformations (AVMs). Mutations in ACVRL1 (ALK1), ENG (endoglin), or SMAD4 disrupt transforming growth factor-beta (TGF-β) signaling, leading to defective vascular remodeling and endothelial cell proliferation. The ACVRL1 gene (chromosome 12q13) and ENG gene (chromosome 9q34) are most frequently implicated, with SMAD4 mutations (chromosome 18q21) associated with a more severe phenotype, including hepatic and pulmonary AVMs.

   Inheritance follows an autosomal dominant pattern with high penetrance, though expressivity varies. Symptoms typically emerge in the second to fourth decades of life, with epistaxis being the most common initial presentation (observed in ~90% of cases). Cerebral AVMs occur in 10–20% of HHT patients, with a 1–2% annual risk of hemorrhage once formed. Cavernous malformations (CM), or cavernous angiomas, are another congenital vascular anomaly linked to CCM1 (KRIT1), CCM2 (MGC4607), and CCM3 (PDCD10) mutations. These lesions consist of dilated, thin-walled vessels lacking intervening brain parenchyma, predisposing to microhemorrhages and seizures. CCM1 mutations (7p13) are the most prevalent, followed by CCM2 (7q11–22) and CCM3 (3q25–27). Hemorrhage risk increases with lesion size (>3 cm) and prior bleeding episodes.
   

   Connective Tissue Disorders and Vascular Fragility

   Connective tissue disorders impair collagen and elastin synthesis, compromising vascular wall integrity. Ehlers-Danlos syndrome (EDS), particularly the vascular type (EDS IV), arises from mutations in the COL3A1 gene (encoding type III collagen), leading to fragile arteries prone to dissection or rupture. Patients often present with spontaneous arterial dissections, aortic aneurysms, or intracranial hemorrhage before age 40. Marfan syndrome, caused by FBN1 mutations (chromosome 15q21), affects fibrillin-1, weakening the aortic root and increasing the risk of subarachnoid hemorrhage (SAH) from ruptured aneurysms or cervical artery dissections.

   Diagnostic red flags include:
   

2. Skin hyperextensibility, easy bruising, or atrophic scarring (EDS).
3. Arachnodactyly, pectus excavatum, or lens dislocation (Marfan syndrome).
4. Family history of aortic dissections or early-onset strokes.

Collagen defects also predispose to pseudoaneurysms and dural ectasias, particularly in the vertebrobasilar system. Imaging may reveal diffuse vascular tortuosity or multifocal aneurysms, necessitating lifelong surveillance.


Rare Congenital Vascular Anomalies and Hemorrhage Patterns

Congenital vascular anomalies beyond HHT and CM include dural arteriovenous fistulas (DAVFs), Moyamoya disease, and venous malformations, each with distinct hemorrhage triggers and age-dependent presentations.

5. Dural arteriovenous fistulas (DAVFs) arise from abnormal connections between dural arteries and venous sinuses, often congenital but occasionally acquired post-trauma or surgery. Pediatric DAVFs frequently involve the transverse/sigmoid sinus, while adult cases often affect the cavernous sinus. Hemorrhage risk correlates with cortical venous drainage (Borden type III) or direct arteriovenous shunting, with ~10% annual hemorrhage risk in high-grade lesions. Symptoms include tinnitus, cranial nerve palsies, or seizures, with SAH occurring in 10–20% of cases.

- Moyamoya disease, characterized by progressive stenosis of the internal carotid arteries and collateral "puff-of-smoke" vessels, primarily affects Asian children (peak age 5–10 years) but also presents in adults. Hemorrhagic strokes account for ~20% of initial presentations, often due to ruptured aneurysms at the stenotic segment or choroidal arteries. Smoking and hypertension exacerbate hemorrhage risk in adults.

- Venous malformations (VMs), such as developmental venous anomalies (DVAs), are typically benign but may hemorrhage if associated with concomitant AVMs or thrombosis. Cavernous sinus VMs pose a higher risk in children, while spinal VMs often present with subarachnoid or epidural hemorrhage in adolescents.


Comparison of Acquired vs. Congenital Hemorrhage Causes

Distinguishing congenital from acquired hemorrhage etiologies relies on family history, cutaneous manifestations, and imaging patterns, particularly in pediatric or young adult patients.

Feature	Congenital Causes	Acquired Causes	Diagnostic Red Flags
Inheritance Pattern	Autosomal dominant (HHT, EDS), autosomal recessive (CM), or sporadic (Moyamoya).	Sporadic (hypertension, amyloid angiopathy) or secondary (vasculitis, coagulopathy).	Positive family history of strokes, epistaxis, or aneurysms in first-degree relatives.
Age of Onset	Pediatric to early adulthood (HHT: 20–40s; CM: any age; Moyamoya: <10 years).	Middle-aged to elderly (amyloid angiopathy: >60 years; hypertensive hemorrhage: >50 years).	Hemorrhage in children/adolescents without trauma or risk factors (e.g., Moyamoya, VMs).
Cutaneous/Physical Findings	Telangiectasias (HHT), skin hyperextensibility (EDS), arachnodactyly (Marfan).	Petechiae (coagulopathy), livedo reticularis (vasculitis), or no visible signs.	Visible vascular lesions (e.g., facial telangiectasias, atrophic scars) or abnormal joint hypermobility.
Imaging Characteristics	Multiple, well-defined CMs (MRI: "popcorn" lesions). AVMs with early venous filling (angiography). Moyamoya: "Smoke" collaterals on MRA/CTA. EDS: Tortuous vessels, pseudoaneurysms.	Lobar hemorrhages (amyloid angiopathy). Basilar SAH (berry aneurysms). Deep hemorrhages (hypertensive microbleeds).	Multiple or atypical hemorrhage locations (e.g., brainstem CMs, spinal VMs) or Brain hemorrhage remains a formidable challenge in neurology, where timely diagnosis and intervention directly correlate with patient outcomes. The interplay between vascular pathology, genetic predisposition, and therapeutic interventions demands a multidisciplinary approach, integrating imaging advancements with evidence-based protocols. From the rupture of Charcot-Bouchard microaneurysms to the complications of lumbar puncture, each etiology presents unique diagnostic and management considerations. By consolidating anatomical distinctions, pharmacological risks, and congenital vulnerabilities, this analysis provides a framework for clinicians to navigate the complexities of hemorrhage prevention and acute care. The future lies in refining risk stratification models and expanding access to minimally invasive treatments, ensuring that every patient receives the precise intervention at the critical moment.